ArticleCellular and molecular life sciences : CMLS2022

Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.

Natalia Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.